Results
1 -
10 of
20
(Click
here to explore results)
Orphan Drugs and Rare Diseases, Chapter 13 Treatments for Pulmonary Arterial Hypertension . Michael J. Palmer
, 2014
, Pages 369-397
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 1 Drugs and their Structural Motifs . Alexander A. Alex, R. Ian Storer
, 2010
, Pages 1-60
Accounts in Drug Discovery: Case Studies in Medicinal Chemistry, Chapter 8 The Discovery of the Long-acting PDE5 Inhibitor PF-489791 for the Treatment of Pulmonary Hypertension . Andrew S. Bell, Michael J. Palmer
, 2011
, Pages 166-182
The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection . Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
Ambient Ionization Mass Spectrometry, Chapter 2 Direct Analysis in Real Time (DART® ) . Robert B. Cody, A. John Dane
, 2015
, Pages 23-57
The Handbook of Medicinal Chemistry: Principles and Practice, CHAPTER 17 Patents for Medicines . Paul A. Brady, Gordon Wright
, 2015
, Pages 424-455
Orphan Drugs and Rare Diseases, Chapter 11 Drug Discovery Approaches for Rare Neuromuscular Diseases . Graham M. Wynne, Angela J. Russell
, 2014
, Pages 257-343
The Handbook of Medicinal Chemistry: Principles and Practice, Subject Index
, 2015
, Pages 715-753
Nutraceuticals and Human Health: The Food-to-supplement Paradigm, Chapter 12 Clinically-relevant Herb–Drug Interactions: Current Status and Practical Considerations . Bill Gurley
, 2020
, Pages 204-231
Orphan Drugs and Rare Diseases, Subject Index
, 2014
, Pages 448-463